Compare REVG & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REVG | BSX |
|---|---|---|
| Founded | 2008 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 137.8B |
| IPO Year | 2017 | 1992 |
| Metric | REVG | BSX |
|---|---|---|
| Price | $65.81 | $99.74 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 4 | 17 |
| Target Price | $48.00 | ★ $125.88 |
| AVG Volume (30 Days) | 587.1K | ★ 8.9M |
| Earning Date | 12-10-2025 | 02-04-2026 |
| Dividend Yield | ★ 0.37% | N/A |
| EPS Growth | N/A | ★ 54.68 |
| EPS | ★ 1.89 | 1.87 |
| Revenue | $2,463,500,000.00 | ★ $19,349,000,000.00 |
| Revenue This Year | $9.52 | $21.05 |
| Revenue Next Year | $7.89 | $11.44 |
| P/E Ratio | ★ $34.42 | $52.75 |
| Revenue Growth | 3.50 | ★ 21.61 |
| 52 Week Low | $26.51 | $85.98 |
| 52 Week High | $66.49 | $109.50 |
| Indicator | REVG | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 70.86 | 62.88 |
| Support Level | $60.43 | $93.86 |
| Resistance Level | $66.49 | $96.33 |
| Average True Range (ATR) | 1.39 | 1.45 |
| MACD | 0.28 | 0.63 |
| Stochastic Oscillator | 89.89 | 83.52 |
REV Group Inc is a U.S.-based designer, manufacturer, and distributor of specialty vehicles and related aftermarket parts and services, operating through two segments: Specialty Vehicles and Recreational Vehicles. The Specialty Vehicles segment includes fire apparatus, ambulances, terminal trucks, and sweepers sold under brands such as E-One, Ferrara, KME, Spartan ER, AEV, Horton, Leader, Road Rescue, Wheeled Coach, Capacity, and LayMor. The Recreational Vehicles segment includes American Coach, Fleetwood RV, Holiday Rambler, Renegade RV, and Midwest Automotive Designs, offering Class A, B, C, and Super C motorized RVs and products from Goldshield Fiberglass. The majority of revenue is generated from the Specialty Vehicles segment.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.